1. Home
  2. CDNA vs RYI Comparison

CDNA vs RYI Comparison

Compare CDNA & RYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • RYI
  • Stock Information
  • Founded
  • CDNA 1998
  • RYI 1842
  • Country
  • CDNA United States
  • RYI United States
  • Employees
  • CDNA N/A
  • RYI N/A
  • Industry
  • CDNA Medical Specialities
  • RYI Metal Fabrications
  • Sector
  • CDNA Health Care
  • RYI Industrials
  • Exchange
  • CDNA Nasdaq
  • RYI Nasdaq
  • Market Cap
  • CDNA 712.2M
  • RYI 699.3M
  • IPO Year
  • CDNA 2014
  • RYI N/A
  • Fundamental
  • Price
  • CDNA $15.19
  • RYI $24.43
  • Analyst Decision
  • CDNA Buy
  • RYI Hold
  • Analyst Count
  • CDNA 8
  • RYI 1
  • Target Price
  • CDNA $26.86
  • RYI $25.00
  • AVG Volume (30 Days)
  • CDNA 1.3M
  • RYI 223.1K
  • Earning Date
  • CDNA 11-03-2025
  • RYI 10-28-2025
  • Dividend Yield
  • CDNA N/A
  • RYI 3.07%
  • EPS Growth
  • CDNA N/A
  • RYI N/A
  • EPS
  • CDNA 1.00
  • RYI N/A
  • Revenue
  • CDNA $340,826,000.00
  • RYI $4,439,000,000.00
  • Revenue This Year
  • CDNA $12.73
  • RYI $0.20
  • Revenue Next Year
  • CDNA $11.90
  • RYI $3.78
  • P/E Ratio
  • CDNA $15.23
  • RYI N/A
  • Revenue Growth
  • CDNA 14.72
  • RYI N/A
  • 52 Week Low
  • CDNA $10.96
  • RYI $17.18
  • 52 Week High
  • CDNA $32.76
  • RYI $27.41
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 60.38
  • RYI 64.51
  • Support Level
  • CDNA $14.28
  • RYI $22.29
  • Resistance Level
  • CDNA $15.21
  • RYI $23.18
  • Average True Range (ATR)
  • CDNA 0.60
  • RYI 0.74
  • MACD
  • CDNA 0.02
  • RYI 0.14
  • Stochastic Oscillator
  • CDNA 72.48
  • RYI 100.00

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About RYI Ryerson Holding Corporation

Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. Its customers range from local, independently owned fabricators and machine shops to large, international original equipment manufacturers. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company generates substantially all of its revenue from sales of metal products. Geographically, the majority revenue is generated from the United States.

Share on Social Networks: